Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitis

Immune checkpoint inhibitor-associated colitis (ICIC) affects approximately 15% of cancer patients treated with immunotherapy. Although histological evaluation is potentially valuable for both the diagnosis of ICIC and evaluation of disease activity, use in clinical practice is heterogeneous. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Christopher, Pai, Rish K, Schaeffer, David F, Krell, Jonathan, Guizzetti, Leonardo, McFarlane, Stefanie C, MacDonald, John K, Choi, Won-Tak, Feakins, Roger M, Kirsch, Richard, Lauwers, Gregory Y, Pai, Reetesh K, Rosty, Christophe, Srivastava, Amitabh, Walsh, Joanna C., Feagan, Brian G, Jairath, Vipul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928359/
https://www.ncbi.nlm.nih.gov/pubmed/35296560
http://dx.doi.org/10.1136/jitc-2022-004560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928359/
https://www.ncbi.nlm.nih.gov/pubmed/35296560
http://dx.doi.org/10.1136/jitc-2022-004560

Ejemplares similares